Vanessa Muniz‐Medina

A Simple Method for Quantifying Functional Selectivity and Agonist Bias

Terry Kenakin, Christian Watson, Vanessa Muniz‐Medina et al. · ACS Chemical Neuroscience · 2011 · 486 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina et al. · Cancer Cell · 2016 · 390 citations · Full text

Medicine, Oncology, Pharmacology +14

Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients

Sikandar G. Khan, Kyu‐Seon Oh, Tala Shahlavi et al. · Carcinogenesis · 2005 · 98 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Ras-mediated Loss of the Pro-apoptotic Response Protein Par-4 Is Mediated by DNA Hypermethylation through Raf-independent and Raf-dependent Signaling Cascades in Epithelial Cells

Kevin Pruitt, Aylin S. Ülkü, Karen Frantz et al. · Journal of Biological Chemistry · 2005 · 94 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

The Relative Activity of “Function Sparing” HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?

Vanessa Muniz‐Medina, Stacey A. Jones, Jodi M. Maglich et al. · Molecular Pharmacology · 2008 · 78 citations

Medicine, Medicinal Chemistry, Pharmacology +17